Artificial Intelligence is no longer a luxury reserved for high-income countries. In a newly published perspective, researchers Dr. Htet Lin Aung (Harvard Medical School) and Dr. Kaung Wai Yan Lwin (University of Medicine 2, Yangon) argue that AI’s greatest impact may be felt in low- and middle-income countries (LMICs), where workforce shortages and geographic isolation remain critical barriers to care.

The Great Equalizer: Empowering Patients and Clinicians

The research positions AI as an “equalizing agent.” For patients in rural areas, AI-enabled medication checkers provide a safety net, explaining side effects and drug interactions through audio and visual formats. This is particularly vital for low-literacy patients who may struggle with complex written prescriptions.

For healthcare workers facing overwhelming patient volumes, AI serves as a “force multiplier.” By summarizing patient data and providing a virtual “second opinion” on radiological findings, AI alleviates the documentation burden and alerts clinicians to urgent abnormalities in X-rays or ultrasounds—critical in areas where specialists like radiologists are unavailable.

Strategic Highlights: Workflow and Adherence

• Optimized Triage: AI assists in reviewing radiologic findings and prioritizing high-risk cases.
• Medication Safety: Visual tools help reduce errors among patients who struggle with medical instructions.
• Continuity of Care: AI-enabled SMS and voice reminders promote adherence to vaccination and chronic disease appointments.
• Language Bridges: Culturally adapted interfaces help break down barriers to build patient trust.

Addressing Risks and Ethical Governance

The perspective candidly addresses the risks involved. Algorithms trained on data from wealthy nations may carry bias if applied blindly to LMIC contexts. The authors emphasize that AI must augment rather than replace human care.